Model of Detergent-Induced Spectral Changes of the B800-850 Complex from Chromatium minutissimum
摘要:
The absorption and circular dichroism spectra of the B800-850 complex from Chromatium minutissimum before and after the Triton X-100 treatment were simulated by means of standard exciton theory, taking into account inhomogeneous broadening. To explain the spectral changes of the B800-850 complex treated with Triton X-100, we have assumed that all bacteriochlorophyll pigments absorbing at 850 nm exhibit the same additional rotation of similar to 20 degrees around the axis perpendicular to the membrane plane. This has been sufficient to fit the transformation in absorption and circular dichroism spectra induced by detergent treatment of the B800-850 complex.
[EN] COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS<br/>[FR] ASSOCIATIONS D'INHIBITEURS DU VIRUS DE L'HÉPATITE C
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2015005901A1
公开(公告)日:2015-01-15
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
399. Formaldehyde condensations with aliphatic ketones. Part I
作者:Gilbert T. Morgan、Eric Leighton Holmes
DOI:10.1039/jr9320002667
日期:——
Absorbent member for absorbent articles comprising swellable polymers of high permeability which are capable of forming hydrogels
申请人:THE PROCTER & GAMBLE COMPANY
公开号:EP1588723B1
公开(公告)日:2009-06-03
POLYIONIC DENDRIMER AND HYDROGEL COMPRISING SAME
申请人:Japan Science and Technology Agency
公开号:EP2450392B1
公开(公告)日:2014-06-25
[EN] HEPATITIS C VIRUS INHIBITORS<br/>[FR] INHIBITEURS DU VIRUS DE L'HÉPATITE C
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2013106520A1
公开(公告)日:2013-07-18
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.